Specifically, we demonstrate for the first time that chemogenetic inhibition of vAI-PrL and dAI-ovBNST circuits versus targeted enhancement of eCB signaling within these pathways divergently ameliorated headache and anxiety. The gene discussed is PRL; the disease is Anxiety.